KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Current Leases (2019 - 2020)

Historic Current Leases for TherapeuticsMD (TXMD) over the last 2 years, with Q3 2020 value amounting to $2.4 million.

  • TherapeuticsMD's Current Leases rose 9353.66% to $2.4 million in Q3 2020 from the same period last year, while for Sep 2020 it was $2.4 million, marking a year-over-year increase of 9353.66%. This contributed to the annual value of $1.5 million for FY2019, which is N/A changed from last year.
  • Per TherapeuticsMD's latest filing, its Current Leases stood at $2.4 million for Q3 2020, which was up 9353.66% from $1.8 million recorded in Q1 2020.
  • TherapeuticsMD's Current Leases' 5-year high stood at $2.4 million during Q3 2020, with a 5-year trough of $1.2 million in Q1 2019.